ATA151387A - Verfahren zu gewinnung eines neuen liganden und verfahren zur verstaerkung der proliferation von b-zellen - Google Patents

Verfahren zu gewinnung eines neuen liganden und verfahren zur verstaerkung der proliferation von b-zellen

Info

Publication number
ATA151387A
ATA151387A AT0151387A AT151387A ATA151387A AT A151387 A ATA151387 A AT A151387A AT 0151387 A AT0151387 A AT 0151387A AT 151387 A AT151387 A AT 151387A AT A151387 A ATA151387 A AT A151387A
Authority
AT
Austria
Prior art keywords
proliferation
reinforcing
cells
obtaining
new ligand
Prior art date
Application number
AT0151387A
Other languages
English (en)
Other versions
AT398437B (de
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Priority to AT0171892A priority Critical patent/AT400956B/de
Publication of ATA151387A publication Critical patent/ATA151387A/de
Application granted granted Critical
Publication of AT398437B publication Critical patent/AT398437B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT0151387A 1986-06-13 1987-06-15 Verfahren zur gewinnung eines neuen liganden und verfahren zur verstärkung der proliferation von b-zellen AT398437B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0171892A AT400956B (de) 1986-06-13 1992-08-27 Verfahren zur gewinnung eines liganden und verfahren zur unterdrückung der proliferation von bp50 exprimierenden zellen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87388486A 1986-06-13 1986-06-13

Publications (2)

Publication Number Publication Date
ATA151387A true ATA151387A (de) 1994-04-15
AT398437B AT398437B (de) 1994-12-27

Family

ID=25362524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0151387A AT398437B (de) 1986-06-13 1987-06-15 Verfahren zur gewinnung eines neuen liganden und verfahren zur verstärkung der proliferation von b-zellen

Country Status (22)

Country Link
JP (1) JPH0762040B2 (de)
KR (1) KR910004100B1 (de)
AT (1) AT398437B (de)
AU (1) AU617087B2 (de)
BE (1) BE1000587A4 (de)
CA (1) CA1338781C (de)
CH (1) CH676600A5 (de)
CY (1) CY1681A (de)
DE (1) DE3719398C2 (de)
DK (1) DK173940B1 (de)
FR (1) FR2607136B1 (de)
GB (1) GB2191494B (de)
GR (1) GR870930B (de)
HK (1) HK10293A (de)
IE (1) IE60486B1 (de)
IL (1) IL82841A (de)
IT (1) IT1208649B (de)
LU (1) LU86919A1 (de)
NL (1) NL195022C (de)
PT (1) PT85073B (de)
SE (1) SE504675C2 (de)
SG (1) SG118992G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
RS50101B (sr) * 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0117705A3 (de) * 1983-02-24 1985-09-25 The Regents Of The University Of California Monocyten und Blastzellen spezifischer monoklonaler Antikörper
FR2547731A1 (fr) * 1983-06-27 1984-12-28 Centre Nat Rech Scient Immunotoxine antitumorale, preparations pharmaceutiques la contenant et son utilisation in vitro
US4585742A (en) * 1983-12-14 1986-04-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibody with specificity to human small cell carcinoma and use thereof

Also Published As

Publication number Publication date
LU86919A1 (fr) 1989-03-08
JPS6480299A (en) 1989-03-27
JPH0762040B2 (ja) 1995-07-05
AT398437B (de) 1994-12-27
KR910004100B1 (ko) 1991-06-22
DK302287A (da) 1987-12-14
BE1000587A4 (fr) 1989-02-14
FR2607136A1 (fr) 1988-05-27
AU7421487A (en) 1987-12-17
IE871563L (en) 1987-12-13
FR2607136B1 (fr) 1989-09-15
DE3719398C2 (de) 1996-03-28
SG118992G (en) 1993-01-29
PT85073B (pt) 1990-07-31
NL8701371A (nl) 1988-01-04
DE3719398A1 (de) 1988-01-28
GR870930B (en) 1987-12-16
IT8720899A0 (it) 1987-06-12
IT1208649B (it) 1989-07-10
NL195022C (nl) 2003-06-18
DK173940B1 (da) 2002-03-04
PT85073A (en) 1987-07-01
GB2191494A (en) 1987-12-16
IL82841A (en) 1992-11-15
GB8713650D0 (en) 1987-07-15
SE504675C2 (sv) 1997-04-07
SE8702463L (sv) 1987-12-14
IE60486B1 (en) 1994-07-27
HK10293A (en) 1993-02-19
CY1681A (en) 1993-10-10
DK302287D0 (da) 1987-06-12
AU617087B2 (en) 1991-11-21
GB2191494B (en) 1990-08-22
CH676600A5 (de) 1991-02-15
IL82841A0 (en) 1987-12-20
KR880000582A (ko) 1988-03-28
SE8702463D0 (sv) 1987-06-12
CA1338781C (en) 1996-12-10

Similar Documents

Publication Publication Date Title
DE3577393D1 (de) Verfahren und apparatur zur bereitung eines selbsthaertenden zweikomponentenpulverfluessigkeitszementes.
DE58905731D1 (de) Verfahren und vorrichtung zur bestimmung der brechzahl n einer substanz.
DE3855260D1 (de) System und Verfahren zum Zugriff von Ferndateien in einem verteilten Netzwerk
DE3677835D1 (de) Verfahren zum bereiten von infektionsbestaendigen materialien.
DE3687966T2 (de) Verfahren und apparat zur bestimmung einer messgroesse.
DE3776302D1 (de) Verfahren zur feststellung von gasen unter anwendung von chemisorption und physisorption.
DE3584496D1 (de) Verfahren zur aufsaugung und festhaltung von harn.
AT380496B (de) Verfahren und reaktor zur delignifizierung von zellstoff mit sauerstoff
DE3585374D1 (de) Verfahren zur bestimmung von mercaptoverbindungen und dabei zu verwendendes reagenz.
DE3782213D1 (de) Verfahren zur enthalogenierung eines halogenids und katalysator hierfuer.
AT389526B (de) Verfahren zur gewinnung von fluessig-roheisen in einem einschmelzvergaser
DE3785309T2 (de) Verfahren und geraet zur bestimmung der kante eines magnetbandes.
DE3783773T2 (de) Vorrichtung zur feststellung der lebensfaehigkeit von nematoden und verfahren zu ihrer verwendung.
AT362290B (de) Verfahren zur regenerierung und reaktivierung inaktiv gewordenen zementes
AT362530B (de) Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat- -pyruvat-transaminase
ATA15987A (de) Verfahren zur herstellung von neuen aminen
DE3775641D1 (de) Entmetallisierung eines katalysators und verfahren zur verwendung eines entmetallisierten katalysators.
ATA151387A (de) Verfahren zu gewinnung eines neuen liganden und verfahren zur verstaerkung der proliferation von b-zellen
ATA150882A (de) Verfahren und einrichtung zur bestimmung der kinetik der strukturbildung und der adhaesion bei bindemitteln
ATA344187A (de) Verfahren zur bestimmung der dichte einer in einer schwingröhre eines schwingungs-aräometers befindlichen flüssigkeit
AT371463B (de) Verfahren zur herstellung von neuen gammabutyrolactonen und gamma-butyrothiolactonen
DE68922467T2 (de) Verfahren und Anordnung zur Zuweisung von binären Werten zu abgetasteten Werten.
AT361489B (de) Verfahren zur herstellung von neuen pyrrolochinoxalinonen und pyrrolobenzdia- zepinonen
DE3680246D1 (de) Verfahren und system zur vermeidung von ueberspannungen in einem umrichtersystem.
ATA141486A (de) Beschichtungsmasse und verfahren zu dessen aushärtung

Legal Events

Date Code Title Description
ELA Expired due to lapse of time